Meritxell Bellet

Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer

María Teresa Herrera-Abreu, Marta Palafox, Uzma Asghar et al. · Cancer Research · 2016 · 779 citations · Full text

Medicine, Cancer Biology, Oncology +17

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

Prudence A. Francis, Meredith M. Regan, Gini F. Fleming et al. · New England Journal of Medicine · 2014 · 727 citations · Full text

Medicine, Gynecology, Oncology +16

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

Prudence A. Francis, Olivia Pagani, Gini F. Fleming et al. · New England Journal of Medicine · 2018 · 673 citations · Full text

Medicine, Endocrinology, Oncology +17

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer

José Baselga, Peter van Dam, Alexey Manikhas et al. · Journal of Clinical Oncology · 2009 · 658 citations

Medicine, Oncology, Pharmacology +17

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)

Michael Gnant, Amylou C. Dueck, Sophie Frantal et al. · Journal of Clinical Oncology · 2021 · 231 citations · Full text

Medicine, Oncology, Pharmacology +17